1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,630 | 2,680 | 26.04. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors | 199 | PR Newswire | Bioretec Ltd Company announcement 26 April 2024 at 12:15 p.m. EEST
TAMPERE, Finland, April 26, 2024 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 26 April 2024... ► Artikel lesen | |
| 05.04. | Notice of Annual General Meeting (AGM) of Bioretec Ltd | 288 | PR Newswire | Bioretec Ltd Company announcement 5 April 2024 at 3:00 p.m. EET
TAMPERE, Finland, April 5, 2024 /PRNewswire/ -- The shareholders of Bioretec Ltd are hereby invited to the Annual General... ► Artikel lesen | |
| 21.03. | Inside information: Bioretec's RemeOs biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office | 280 | PR Newswire | Bioretec Ltd Inside information 21 March 2024 at 7:00 p.m. EET
TAMPERE, Finland, March 21, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has been... ► Artikel lesen | |
| 15.03. | Bioretec Ltd's Annual Report and Financial Statements 2023 published | 265 | PR Newswire | Bioretec Ltd Company announcement 15 March 2024 at 5:30 p.m. EET
TAMPERE, Finland, March 15, 2024 /PRNewswire/ -- Bioretec Ltd has today published its 2023 Annual Report, Financial Statements... ► Artikel lesen | |
| 14.03. | Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs Spinal Interbody Cage | 240 | PR Newswire | TAMPERE, Finland, March 14, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in biodegradable orthopedic implants, has today been granted Breakthrough Device Designation for its RemeOs Spinal... ► Artikel lesen | |
| 08.03. | Inside information: Bioretec's European market authorization for RemeOs trauma screw has proceeded to expert panel evaluation, the approval is estimated during the Q2 2024 | 452 | PR Newswire | Bioretec Ltd Inside information 8 March 2024 at 9:15 p.m. EET
TAMPERE, Finland, March 8, 2024 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants,... ► Artikel lesen | |
| 16.02. | Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory | 240 | PR Newswire | Bioretec Ltd Company announcement 16 February 2024 at 8:00 a.m.
TAMPERE, Finland, Feb. 16, 2024 /PRNewswire/ -- This announcement is a summary of Bioretec Ltd's financial statements... ► Artikel lesen | |
| 08.02. | Bioretec and Stephen Industries donate medical devices to Ukraine | - | Cision News | ||
| 18.01. | New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register | 2 | Cision News | ||
| 05.01. | Bioretec Ltd - Managers' transactions | 329 | PR Newswire | Bioretec Ltd Managers' transactions 5 January 2024 at 11.00 a.m. EET
TAMPERE, Finland, Jan. 5, 2024 /PRNewswire/ --
Bioretec Oy - Managers' Transactions
Person subject to... ► Artikel lesen | |
| 11.12.23 | Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy | 249 | PR Newswire | Bioretec Ltd Company announcement 11 December 2023 at 5:15 p.m. EET
TAMPERE, Finland, Dec. 11, 2023 /PRNewswire/ -- In the future, in addition to the financial statements bulletin and... ► Artikel lesen | |
| 16.11.23 | Inside information: Bioretec's Board of Directors to initiate a new CEO recruitment process | 382 | PR Newswire | TAMPERE, Finland, Nov. 16, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer of biodegradable orthopedic implants, is initiating a new CEO recruitment process as the company's current CEO, Mr.... ► Artikel lesen | |
| 20.10.23 | Bioretec Ltd's Board of Directors has decided on a new option program 2023-1 | 449 | PR Newswire | TAMPERE, Finland, Oct. 20, 2023 /PRNewswire/ -- The Board of Directors of Bioretec Ltd has on 20 October 2023 decided, on the basis of the authorization received from the company's Annual General... ► Artikel lesen | |
| 18.10.23 | Inside information: Bioretec estimates that the approval of the European market authorization for the biodegradable RemeOs trauma screw will move to the first quarter of 2024 | 383 | PR Newswire | TAMPERE, Finland, Oct. 18, 2023 /PRNewswire/ -- The European market authorization process for Bioretec Ltd's RemeOs trauma screw, a pioneer in biodegradable orthopedic implants, still continues... ► Artikel lesen | |
| 12.09.23 | Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs screws | 412 | PR Newswire | TAMPERE, Finland, Sept. 12, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution agreement for the U.S.... ► Artikel lesen | |
| 06.09.23 | Bioretec has received Business Finland's R&D grant for developing coatings for the next generation of biodegradable implants | 360 | PR Newswire | TAMPERE, Finland, Sept. 6, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has received a grant of a maximum of EUR 0.97... ► Artikel lesen | |
| 16.08.23 | Bioretec unveils its revitalized Scientific Advisory Board (SAB), focusing on driving innovations in orthopedic implants | 444 | PR Newswire | TAMPERE, Finland, Aug. 16, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneering company dedicated to advancing orthopedic biodegradable implants, has refined and expanded its esteemed Scientific... ► Artikel lesen | |
| 11.08.23 | Bioretec Ltd's Half Year Report 2023 (unaudited): Historic achievement supported by the strong sales | 416 | PR Newswire | TAMPERE, Finland, Aug. 11, 2023 /PRNewswire/ -- This is a summary of Bioretec Ltd's half year report 2023. The complete half year report with tables is attached to this release and available... ► Artikel lesen | |
| 13.06.23 | Bioretec Ltd invests in a CNC machining center to increase the RemeOs production capacity | 390 | PR Newswire | TAMPERE, Finland, June 13, 2023 /PRNewswire/ -- Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has acquired a new CNC machining center to increase the production capacity of... ► Artikel lesen | |
| 26.05.23 | Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors | 435 | PR Newswire | TAMPERE, Finland, May 26, 2023 /PRNewswire/ -- The Annual General Meeting of Bioretec Ltd was held on 26 May 2023 in Tampere, Finland.
The Annual General Meeting approved the financial... ► Artikel lesen |
Seite:
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 27,210 | +0,11 % | Cardiol Therapeutics, Bayer AG, Fresenius Aktie - wer ist der Trendsetter im Gesundheitsmarkt von morgen? | Die Gesundheitsbranche ist ein lukratives Segment für risikobewusste Anleger. Die globale Marktgröße für Gesundheitsdienstleistungen wird voraussichtlich bis 2028 eine jährliche Wachstumsrate (CAGR)... ► Artikel lesen | |
| ECKERT & ZIEGLER | 36,720 | +1,89 % | Eckert & Ziegler gutes Q1 - reicht zumindest für Prognosebestätigung. Und Kursfeuerwerk. Eintagsfliege? | Eckert & Ziegler (ISIN: DE0005659700) - Anfang Januar noch beim Platow Brief als klarer KAUF eingestuft - liefert heute im Rahmen einer ad-hoc-Meldung einen vorläufigen Blick auf die Q1-Zahlen, die... ► Artikel lesen | |
| CYTOSORBENTS | 0,750 | -1,06 % | CytoSorbents to Report First Quarter 2024 Operating and Financial Results | ||
| REVENIO GROUP | 23,580 | -6,65 % | Revenio Group Corporation: Interim report January 1 -March 31, 2024 | Revenio Group Corporation | Stock Exchange Release | April 25, 2024 at 09:00:00 EEST
Q1/2024: Soft start for the year as expected, however, net cash flow from operations was strongThe figures in parentheses... ► Artikel lesen | |
| OPTOMED | 3,930 | -3,79 % | Optomed Oyj: Financial Statements Bulletin, January - December 2023 | Optomed Plc Stock Exchange Release 15 February 2024 at 9:00, Helsinki
Optomed Plc: Financial Statements Bulletin, January - December 2023
October - December 2023
Revenue decreased... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 52,94 | +1,22 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,420 | -0,98 % | FMC: Erfolge werden deutlicher | Fresenius Medical Care (FMC) erwirtschaftet derzeit rund 70 Prozent des Umsatzes in den USA. Dabei ist das dortige Geschäft überdurchschnittlich profitabel für FMC. Sollte es in dem Land zu Steuersenkungen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 100,30 | +1,31 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 51,83 | -0,86 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 100,50 | +1,31 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
| PROGYNY | 32,040 | -1,42 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,890 | +0,46 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| NEWGENIVF GROUP | 1,780 | +36,92 % | Pre-market Movers: Tevogen Bio, Freight Technologies, NewGenIvf Group, Snap, U.S. Silica | MOUNTAIN VIEW (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 09.15 A.M. ET).In the Green Tevogen Bio Holdings Inc. (TVGN) is up over... ► Artikel lesen | |
| ATRICURE | 23,170 | +2,48 % | AtriCure upgraded at Oppenheimer on valuation | ||
| ADAPTHEALTH | 9,960 | +3,97 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |
Das Unternehmen BIORETEC OY kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,570 Euro und damit +0,78 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
